Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Dare Bioscience, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q4 2024
- Shares held
- 827.0K
- +49.8K (+6.4%) vs. Q4 2024
- Total value
- $2.39M
- −$34.9K (−1.4%) vs. Q4 2024
- New holders
- 0
- 8 more added
- Sold out
- 1
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Putney Financial Group LLC | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7 | $20 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 17 | $49 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 19 | $55 | 0.00% | −2−9.5% | Reduced |
| Advisor Group Holdings, Inc. | 25 | $72 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 42 | $121 | 0.00% | 00.0% | Unchanged |
| Mather Group, LLC. | 84 | $243 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 87 | $252 | 0.00% | +4+4.8% | Added |
| SBI Securities Co., Ltd. | 575 | $1.66K | 0.00% | 00.0% | Unchanged |
| Insight Financial Services | 950 | $2.75K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,442 | $4.17K | 0.00% | −194−11.9% | Reduced |
| Allworth Financial LP | 1,667 | $5.00K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 10,491 | $31.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,044 | $43.5K | 0.00% | +74+0.5% | Added |
| Commonwealth Equity Services, LLC | 16,685 | $48.0K | 0.00% | +50+0.3% | Added |
| BlackRock, Inc. | 16,971 | $49.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 22,091 | $63.8K | 0.00% | −10,302−31.8% | Reduced |
| State Street Corp | 23,515 | $68.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 58,164 | $168.1K | 0.00% | +17,582+43.3% | Added |
| Renaissance Technologies LLC | 70,595 | $204.0K | 0.00% | +1,900+2.8% | Added |
| Geode Capital Management, LLC | 95,905 | $277.2K | 0.00% | +3,252+3.5% | Added |
| AMH Equity Ltd | 164,302 | $474.8K | 0.73% | +14,302+9.5% | Added |
| Vanguard Group Inc | 328,328 | $948.9K | 0.00% | +39,703+13.8% | Added |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,584−100.0% | Sold out |